Superseded · version 1: Maridebart cafraglutide^↗

Related names recorded in this version: MariTide, AMG 133^↗

An antibody-peptide conjugate candidate represented in ClinicalTrials.gov.^↗

This is preserved historical wording.
It is no longer the current profile. Read the current profile and its correction notice.

What this version reported

ClinicalTrials.gov lists an Amgen bioavailability study as completed, updated July 21, 2026.^↗

Organizations named in cited records:

Trial records: NCT07717814